Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyu Bian

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 3, 2015
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapyHuizi Sha, Zhengyun Zou, Kai Xin, et al.
Plos One|October 15, 2013
SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimenJie Shen, Jia Wei, Hao Wang, et al.
ACS Nano|June 24, 2026
A Defined Xeno-Free Matrix Supports Midbrain Dopaminergic Cell DifferentiationTian Wang, Ya Zeng, Jun Xue, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 3, 2015
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapyHuizi Sha, Zhengyun Zou, Kai Xin, et al.
Plos One|October 15, 2013
SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimenJie Shen, Jia Wei, Hao Wang, et al.
ACS Nano|June 24, 2026
A Defined Xeno-Free Matrix Supports Midbrain Dopaminergic Cell DifferentiationTian Wang, Ya Zeng, Jun Xue, et al.
Pageof 4